Aiping Young

825 total citations
26 papers, 712 citations indexed

About

Aiping Young is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Aiping Young has authored 26 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Oncology. Recurrent topics in Aiping Young's work include Virus-based gene therapy research (6 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Cancer Research and Treatments (3 papers). Aiping Young is often cited by papers focused on Virus-based gene therapy research (6 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Cancer Research and Treatments (3 papers). Aiping Young collaborates with scholars based in Canada, United States and Jordan. Aiping Young's co-authors include James R. Wright, Aikaterini Vassilakos, Hongnan Jin, Ningping Feng, Yoon Lee, Raed A. Al‐Qawasmeh, Yoon Lee, Xiaoping Gu, Jeff Lightfoot and Jim Wright and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Aiping Young

25 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aiping Young Canada	14	311	181	157	149	77	26	712
Pavel B. Davidovich Russia	13	241 0.8×	154 0.9×	108 0.7×	138 0.9×	43 0.6×	31	548
Xiaolin Xiong China	13	263 0.8×	140 0.8×	166 1.1×	113 0.8×	55 0.7×	33	706
Masanori Kitahara Japan	6	228 0.7×	104 0.6×	475 3.0×	204 1.4×	30 0.4×	8	999
Ziwei Xiao Singapore	15	375 1.2×	202 1.1×	171 1.1×	110 0.7×	64 0.8×	31	747
Haiyang Wang China	11	230 0.7×	262 1.4×	50 0.3×	164 1.1×	67 0.9×	23	553
Ko‐Chung Lin United States	12	275 0.9×	117 0.6×	223 1.4×	151 1.0×	34 0.4×	13	736
Florence Bouyer France	10	250 0.8×	249 1.4×	57 0.4×	130 0.9×	91 1.2×	15	566
Ota Fuchs Czechia	18	569 1.8×	164 0.9×	37 0.2×	110 0.7×	101 1.3×	67	1.0k
Sara A. Johnson United States	12	296 1.0×	61 0.3×	69 0.4×	505 3.4×	24 0.3×	18	988

Countries citing papers authored by Aiping Young

Since Specialization

Citations

This map shows the geographic impact of Aiping Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Young more than expected).

Fields of papers citing papers by Aiping Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiping Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Young. The network helps show where Aiping Young may publish in the future.

Co-authorship network of co-authors of Aiping Young

This figure shows the co-authorship network connecting the top 25 collaborators of Aiping Young. A scholar is included among the top collaborators of Aiping Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiping Young. Aiping Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferdinandi, Eckhardt S., Aikaterini Vassilakos, Yoon Lee, et al.. (2010). Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2. Cancer Chemotherapy and Pharmacology. 68(1). 193–205. 9 indexed citations

Al‐Qawasmeh, Raed A., et al.. (2010). Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 20(12). 3518–3520. 31 indexed citations

Huesca, Mario, Lisa Lock, Aye Aye Khine, et al.. (2009). A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis. Molecular Cancer Therapeutics. 8(9). 2586–2596. 26 indexed citations

Benatar, Tania, Ming Cao, Yoon Lee, et al.. (2009). IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo. Cancer Immunology Immunotherapy. 59(6). 805–817. 83 indexed citations

Benatar, Tania, Ming Cao, Youn‐Bok Lee, et al.. (2008). Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunology Immunotherapy. 57(12). 1757–1769. 43 indexed citations

Al‐Qawasmeh, Raed A., Yoon Lee, Xiaoping Gu, et al.. (2008). 11-Phenyl-[b,e]-dibenzazepine compounds: Novel antitumor agents. Bioorganic & Medicinal Chemistry Letters. 19(1). 104–107. 25 indexed citations

Lee, Yoon, Ningping Feng, Hongnan Jin, et al.. (2007). RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo. Anti-Cancer Drugs. 18(4). 377–388. 13 indexed citations

Li, Hui, Ming Cao, Yoon Lee, et al.. (2007). Virulizin®, a novel immunotherapy agent, stimulates TNFα expression in monocytes/macrophages in vitro and in vivo. International Immunopharmacology. 7(10). 1350–1359. 9 indexed citations

Lee, Yoon, Aikaterini Vassilakos, Ningping Feng, et al.. (2006). Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin. Anti-Cancer Drugs. 17(2). 143–154. 6 indexed citations

10.

Desai, Anjali, Richard L. Schilsky, Aiping Young, et al.. (2005). A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors. Annals of Oncology. 16(6). 958–965. 49 indexed citations

11.

Vassilakos, Aikaterini, et al.. (2005). Optimization of the PAXgene™ blood RNA extraction system for gene expression analysis of clinical samples. Journal of Clinical Laboratory Analysis. 19(5). 182–188. 70 indexed citations

12.

Li, Hui, Ming Cao, Yoon Lee, et al.. (2005). Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages. Cancer Immunology Immunotherapy. 54(11). 1115–1126. 11 indexed citations

13.

Liu, Jubo, Helen Lee, Mario Huesca, Aiping Young, & Christine Allen. (2005). Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy. Cancer Chemotherapy and Pharmacology. 58(3). 306–318. 41 indexed citations

14.

Cao, Ming, Yoon Lee, Ningping Feng, et al.. (2004). NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin. Cancer Immunology Immunotherapy. 54(3). 229–242. 9 indexed citations

15.

Lee, Yoon, Ningping Feng, Raed A. Al‐Qawasmeh, et al.. (2004). NC381, a Novel Anticancer Agent, Arrests the Cell Cycle in G0-G1 and Inhibits Lung Tumor Cell Growth in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 308(2). 538–546. 19 indexed citations

16.

Al‐Qawasmeh, Raed A., Yoon Lee, Xiaoping Gu, et al.. (2003). Triaryl methane derivatives as antiproliferative agents. Bioorganic & Medicinal Chemistry Letters. 14(2). 347–350. 100 indexed citations

17.

Du, Caigan, Ningping Feng, Hongnan Jin, et al.. (2003). Preclinical efficacy of Virulizin in human breast, ovarian and prostate tumor models. Anti-Cancer Drugs. 14(4). 289–294. 6 indexed citations

18.

Feng, Ningping, Hongnan Jin, Ming Wang, et al.. (2003). Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts. Cancer Chemotherapy and Pharmacology. 51(3). 247–255. 10 indexed citations

19.

Lee, Yoon, Aikaterini Vassilakos, Ningping Feng, et al.. (2003). GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.. PubMed. 63(11). 2802–11. 77 indexed citations

20.

Du, Caigan, Ningping Feng, Hongnan Jin, et al.. (2003). Macrophages play a critical role in the anti-tumor activity of Virulizin®. International Journal of Oncology. 23(5). 1341–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact